Cefoperazone-treated mouse model of clinically-relevant clostridium difficile strain R20291

Journal of Visualized Experiments

Volumn 2016, Issue 118, 2016, Pages

  Winston, Jenessa A ^a   Thanissery, Rajani ^a   Montgomery, Stephanie A ^b   Theriot, Casey M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Clostridium difficile; Colonization; Cytotoxicity; Histology; Infection; Inflammation; Issue 118; Mouse model; Vero cells

Indexed keywords

ANTIINFECTIVE AGENT; CEFOPERAZONE;

ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HUMAN; MOUSE; PEPTOCLOSTRIDIUM DIFFICILE;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; CLOSTRIDIUM DIFFICILE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL;

EID: 85008698605     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/54850     Document Type: Article

References (34)

1. Services., U. S. D. o. H. a. H. Antibiotic Resistance Threats in the United States. (2013).
2. Lessa, F. C. et al. Burden of Clostridium difficile Infection in the United States. New England Journal of Medicine 372, 825-834 (2015).
3. Gerding, D. N., & Lessa, F. C. The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect Dis Clin North Am. 29, 37-50 (2015).
4. Dubberke, E. R., & Olsen, M. A. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 55 Suppl 2, S88-92 (2012).
5. Kociolek, L. K., & Gerding, D. N. Breakthroughs in the treatment and prevention of Clostridium difficile infection. Nat Rev Gastroenterol Hepatol. (2016).
6. Kelly, C. P., & LaMont, J. T. Clostridium difficile--more difficult than ever. N Engl J Med. 359, 1932-1940 (2008).
7. Louie, T. J. et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364, 422-431 (2011).
8. Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. The Journal of infectious diseases. 136, 701-705 (1977).
9. Kelly, M. L. et al. Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection. Anaerobe. (2016).
10. Kuehne, S. A. et al. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. The Journal of infectious diseases. 209, 83-86 (2014).
11. Bartlett, J. G., Onderdonk, A. B., & Cisneros, R. L. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology. 73, 772-776 (1977).
12. Chen, X. et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 135, 1984-1992 (2008).
13. Lawley, T. D., & Young, V. B. Murine models to study Clostridium difficile infection and transmission. Anaerobe. 24, 94-97 (2013).
14. Best, E. L., Freeman, J., & Wilcox, M. H. Models for the study of Clostridium difficile infection. Gut Microbes. 3, 145-167 (2012).
15. Reeves, A. E. et al. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2, 145-158 (2014).
16. Owens, R. C., Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 46 Suppl 1, S19-31 (2008).
17. Theriot, C. M. et al. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2, 326-334 (2011).
18. Martin, J. S., Monaghan, T. M., & Wilcox, M. H. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol. (2016).
19. Connor, J. R., Johnson, S., & Gerding, D. N. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 136, 1913-1924 (2009).
20. He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 45, 109-113 (2013).
21. Perez, J., Springthorpe, V. S., & Sattar, S. A. Clospore: a liquid medium for producing high titers of semi-purified spores of Clostridium difficile. Journal of AOAC International. 94, 618-626 (2011).
22. Sorg, J. A., & Dineen, S. S. Laboratory maintenance of Clostridium difficile. Curr Protoc Microbiol Chapter 9, Unit9A.1 (2009).
23. Edwards, A. N., Suarez, J. M., & McBride, S. M. Culturing and maintaining Clostridium difficile in an anaerobic environment. Journal of visualized experiments: JoVE. e50787 (2013).
24. George, W. L., Sutter, V. L., Citron, D., & Finegold, S. M. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 9, 214-219 (1979).
25. Knoblaugh, S., Randolph-Habecker, J., & Rath, S. in Comparative Anatomy and Histology. (ed Suzanne M. Dintzis) 15-40 Academic Press, (2012).
26. Ammerman, N. C., Beier-Sexton, M., & Azad, A. F. Growth and maintenance of Vero cell lines. Curr Protoc Microbiol. Appendix 4, Appendix 4E (2008).
27. Clostridium difficile Toxin/Antitoxin Kit Cat No.T5000. (2007).
28. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 5, 3114 (2014).
29. Koenigsknecht, M. J. et al. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect Immun. 83, 934-941 (2015).
30. Theriot, C., Bowman, A., & Young, V. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine. mSphere. 1, 00045-00015 (2016).
31. Xiao, L. et al. A catalog of the mouse gut metagenome. Nature biotechnology. 33, 1103-1108 (2015).
32. Leslie, J. L. et al. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect Immun. 83, 138-145 (2015).
33. Stabler, R. A. et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10, R102 (2009).
34. Valiente, E., Dawson, L. F., Cairns, M. D., Stabler, R. A., & Wren, B. W. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol. 61, 49-56 (2012).